Digan, Leonardo .

HRN: 25-18-97  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/11/2026
CEFUROXIME 750MG (VIAL)
03/11/2026
03/17/2026
IV
750mg
Q8
UTI
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Urinary Tract    Compliance to guidelines: